Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).
about
The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series)Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic.Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging.Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.Myocardial deformation in aortic valve stenosis: relation to left ventricular geometry.Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients.The Norwegian Stroke in the Young Study (NOR-SYS): rationale and designContrast stress echocardiography in hypertensive heart disease.Left Ventricular Geometry on Transthoracic Echocardiogram and Prognosis after Lacunar Stroke: The SPS3 Trial.Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve StenosisThe renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle Study.Comparative effectiveness of antihypertensive treatment for older children with primary hypertension: study protocol for a series of n-of-1 randomized trialsAssociations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.Relationship between body composition and left ventricular geometry using three dimensional cardiovascular magnetic resonance.Prevalence of residual left ventricular structural changes after one year of antihypertensive treatment in patients of African descent: role of 24-hour pulse pressure.Increased relative wall thickness is a marker of subclinical cardiac target-organ damage in African diabetic patients.Sex Differences in the Associations of Hemodynamic Load With Left Ventricular Hypertrophy and Concentric RemodelingLeft ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study.Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: a meta-analysis.Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand?Myocardial remodeling in hypertension.Congenital left ventricular outpouchings: a systematic review of 839 cases and introduction of a novel classification after two centuries.Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta.Obesity and left ventricular hypertrophy: the hypertension connection.Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications.The paradox of obesity cardiomyopathy and the potential for weight loss as a therapy.Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study.Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study.Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis.Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)Systolic blood pressure values might further risk-stratify the adverse outcomes of LVH in older patients with chronic kidney disease.Prevalence and covariates of abnormal left ventricular geometry in never-treated hypertensive patients in Tanzania.Association of heart rate and left ventricular structure in a rural population in Korea.Favorable changes in arterial elasticity, left ventricular mass, and diastolic function after significant weight loss following laparoscopic sleeve gastrectomy in obese individuals.Left ventricular function in children and adults after renal transplantation in childhood.Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on HypertensioEchocardiographic left ventricular reverse remodeling after 18 months of antihypertensive treatment in stage I hypertension. Results from the PREVER-treatment study.Liver growth factor treatment restores cell-extracellular matrix balance in resistance arteries and improves left ventricular hypertrophy in SHR.Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study).
P2860
Q26781681-108D68A4-EEA4-4CF5-A363-664B5D2765A2Q30250365-8677C2DF-2D11-478C-A366-05E19D56375EQ30444223-17CCC03E-7FBC-45C3-8644-72FEB584014EQ33559608-86CDBC72-BE15-482E-BB79-97C75ECE2718Q33574185-9DFB0C2C-B9F0-41B0-927C-995CB8C874A1Q34316673-4787C319-3343-45D9-9F30-9DE44FD2DD6DQ34831733-4AD24525-1EDC-44D1-BEE4-816B8E0E64AFQ35640831-99B6C04E-A7CB-460A-8FDB-BDFF59875BD1Q35688935-36D68B13-ED27-4246-A01F-31BB6DFD59F4Q36287921-23C98DF4-A672-4B2D-AD24-027622B1413CQ36366106-7A1A465D-1010-44CD-80FF-442D442252AAQ36446320-F41DD1EE-38BA-4E99-AD08-ACE3E3D6859CQ36543089-967ACBB4-4936-477F-8CA5-086FEF470066Q36955565-CF3F9958-254B-4885-9376-23E182324BD7Q37041667-6046BDEF-DBC6-4769-9B6D-5BA04C97B2F9Q37041769-AB31F903-75AE-4CE4-8FEB-1DC375B303B5Q37238169-A3A5518C-6C55-447B-99BA-4DE12EEF9CE4Q37434977-03AA2138-39B7-408B-A173-7024B17FD572Q37555936-AACCCCC1-F5D0-4DB8-885F-054527900B96Q37853841-4D27CFCB-CA4A-416F-A5BF-FA09A7A4BBA0Q38148620-8C9359FC-C41A-450A-A655-8CB189DFC785Q38209968-3D3B0575-8D36-4AD3-8804-18FE3252B3B1Q38243510-4C9FFA68-311B-42FC-908C-DDB62AEE2A48Q38262422-0A6A3A34-C870-4895-BED1-EAC982EB2FD8Q38385756-BA18463A-718E-4A11-A3C2-AD2A021934A0Q38492359-D706428A-AE9C-41DB-A27B-A7DAAA328312Q38533878-4FEC7C00-D59F-41E9-AB7D-4601FFC7E428Q39317074-E5FD409D-3E47-42E5-BA9D-3CFCBA01EBEAQ40110185-CC4C3600-FF6A-41AC-BC77-BAB1F32AE412Q40715496-7C71CCBD-DE37-4EA3-AB92-1E87D8ACDA21Q41103777-6C2E212B-AAB8-4A22-969F-8F65FCCFD36DQ42003531-A162CDC1-8407-4612-B5A8-03241BEDCF97Q43936948-EFD1910E-3590-4290-9C8D-B752D0C218E1Q45108163-D6C741F2-7786-4A40-8C73-7DF943863DEBQ47204125-3ECB39E2-BB54-41E4-B74F-E078A3B22579Q48791707-30060A65-33BD-41F4-8495-4A3553522C0BQ49607622-8902EFE8-5217-449E-9117-4EFC0B7A7453Q50074733-CE0E3A16-2FEF-4782-B4A3-E83CF67499A2Q50533707-25D746CC-8A1F-4FFD-A8CF-5777442694FAQ51240033-2D1F4504-E86F-48FC-B084-484DF2DFA7D7
P2860
Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Impact of left ventricular geo ...... hypertrophy (the LIFE study).
@en
Impact of left ventricular geo ...... h left ventricular hypertrophy
@nl
type
label
Impact of left ventricular geo ...... hypertrophy (the LIFE study).
@en
Impact of left ventricular geo ...... h left ventricular hypertrophy
@nl
prefLabel
Impact of left ventricular geo ...... hypertrophy (the LIFE study).
@en
Impact of left ventricular geo ...... h left ventricular hypertrophy
@nl
P2093
P2860
P50
P356
P1476
Impact of left ventricular geo ...... hypertrophy (the LIFE study).
@en
P2093
Dana Cramariuc
Eva Gerdts
Kristian Wachtell
P2860
P304
P356
10.1093/EJECHOCARD/JEN155
P577
2008-05-13T00:00:00Z